KDA πŸ“ˆ KDA - Overview

Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA48669F1071

KDA: Prescription Platforms, Virtual Resources, Clinical Management, Patient Portals

KDA Group Inc., together with its subsidiaries, provides technological solutions to general and specialized health sectors in Canada. It offers Prescripteur KRx, an electronic prescription platform assisting dentists in practice; KRx Cannabinoid, an electronic prescription platform helping doctors in practice for prescribing medical cannabis; Adherize (ADRX), a suite of virtual resources to present and share crucial information for doctors and pharmacists, as well as a patient portal allows easy access to personalized information; and Medherize, a platform for clinical management of patients requiring specialized medication. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada. Web URL: https://groupekda.ca

Additional Sources for KDA Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

KDA Stock Overview

Market Cap in USD 31m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

KDA Stock Ratings

Growth 5y 0.17%
Fundamental -
Dividend -
Rel. Strength Industry 1990
Analysts -
Fair Price Momentum 0.27 CAD
Fair Price DCF -

KDA Dividends

No Dividends Paid

KDA Growth Ratios

Growth Correlation 3m -21.9%
Growth Correlation 12m -28.5%
Growth Correlation 5y 7%
CAGR 5y 1.39%
CAGR/Mean DD 5y 0.03
Sharpe Ratio 12m 0.71
Alpha 13.40
Beta 0.58
Volatility 181.58%
Current Volume 18k
Average Volume 20d 130k
What is the price of KDA stocks?
As of December 21, 2024, the stock is trading at CAD 0.30 with a total of 18,000 shares traded.
Over the past week, the price has changed by +3.57%, over one month by +31.82%, over three months by +5.45% and over the past year by +48.72%.
Is KDA a good stock to buy?
Neither. Based on ValueRay Analyses, KDA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 0.17 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KDA as of December 2024 is 0.27. This means that KDA is currently overvalued and has a potential downside of -10%.
Is KDA a buy, sell or hold?
KDA has no consensus analysts rating.
What are the forecast for KDA stock price target?
According to ValueRays Forecast Model, KDA KDA will be worth about 0.3 in December 2025. The stock is currently trading at 0.30. This means that the stock has a potential downside of -3.33%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.3 -3.3%